InDex Pharmaceuticals Holding AB (INDEX) - Financial and Strategic SWOT Analysis Review

  • ID: 4281652
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
InDex Pharmaceuticals Holding AB (InDex Pharmaceuticals) is a pharmaceutical development company that offers treatments for immunological diseases. The company provides lead compound kappaproct, which is in clinical development for the treatment of moderate to severe treatment active refractory ulcerative colitis. It also offers DIMS 9054, a DNA based immune modulator sequence in development for treating resistant pulmonary inflammation and reduces the effect of corticosteroids. InDex Pharmaceuticals develops dibicol, a PCR-based method that monitors proprietary biomarkers used for ulcerative colitis or crohn’s disease from a single colonic biopsy. The company conducts clinical studies in the Czech Republic, France, Germany, Hungary, Spain and Ukraine. InDex Pharmaceuticals is headquartered in Stockholm, Sweden.

InDex Pharmaceuticals Holding AB Key Recent Developments

May 17, 2018: InDex Pharmaceuticals Holding interim report January - March 2018
Feb 26, 2018: InDex Pharmaceuticals Holding Year end Report 2017
Nov 17, 2017: InDex Pharmaceuticals Interim Report January - September 2017
Nov 16, 2017: InDex Pharmaceuticals Holding announces Nomination Committee and financial reporting dates for 2018
Aug 25, 2017: InDex Pharmaceuticals Holding interim report January - June 2017

This comprehensive SWOT profile of InDex Pharmaceuticals Holding AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of InDex Pharmaceuticals Holding AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • InDex Pharmaceuticals Holding AB - Key Information
  • InDex Pharmaceuticals Holding AB - Overview
  • InDex Pharmaceuticals Holding AB - Key Employees
  • InDex Pharmaceuticals Holding AB - Key Employee Biographies
  • InDex Pharmaceuticals Holding AB - Key Operational Heads
  • InDex Pharmaceuticals Holding AB - Major Products and Services
  • InDex Pharmaceuticals Holding AB - History
  • InDex Pharmaceuticals Holding AB - Company Statement
  • InDex Pharmaceuticals Holding AB - Locations And Subsidiaries
  • InDex Pharmaceuticals Holding AB - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • InDex Pharmaceuticals Holding AB - Business Description
  • InDex Pharmaceuticals Holding AB - Corporate Strategy
  • InDex Pharmaceuticals Holding AB - SWOT Analysis
  • SWOT Analysis - Overview
  • InDex Pharmaceuticals Holding AB - Strengths
  • InDex Pharmaceuticals Holding AB - Weaknesses
  • InDex Pharmaceuticals Holding AB - Opportunities
  • InDex Pharmaceuticals Holding AB - Threats
  • InDex Pharmaceuticals Holding AB - Key Competitors
Section 3 - Company Financial Performance Charts
  • InDex Pharmaceuticals Holding AB - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • InDex Pharmaceuticals Holding AB, Key Information
  • InDex Pharmaceuticals Holding AB, Key Ratios
  • InDex Pharmaceuticals Holding AB, Share Data
  • InDex Pharmaceuticals Holding AB, Major Products and Services
  • InDex Pharmaceuticals Holding AB, History
  • InDex Pharmaceuticals Holding AB, Key Employees
  • InDex Pharmaceuticals Holding AB, Key Employee Biographies
  • InDex Pharmaceuticals Holding AB, Key Operational Heads
  • InDex Pharmaceuticals Holding AB, Other Locations
  • InDex Pharmaceuticals Holding AB, Subsidiaries
  • InDex Pharmaceuticals Holding AB, Key Manufacturing facilities
  • InDex Pharmaceuticals Holding AB, Key Competitors
  • InDex Pharmaceuticals Holding AB, SWOT Analysis
  • InDex Pharmaceuticals Holding AB, Ratios based on current share price
  • InDex Pharmaceuticals Holding AB, Annual Ratios
  • InDex Pharmaceuticals Holding AB, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • InDex Pharmaceuticals Holding AB, Performance Chart
  • InDex Pharmaceuticals Holding AB, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll